Clinical trial
The Proton Pump Inhibitor Test in Reflux Disease: a Study Using Nexium in General Practice Patients
NCT00318084 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Proton Pump Inhibitor Test in Reflux Disease: a Study Using Nexium in General Practice Patients
- Lead sponsor
- AstraZeneca
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- Not reported
- Enrollment
- 100
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gerd